R&D OUTSOURCING TO INCREASE 30% YEARLY FOR FIVE TO 10 YEARS, CORNING VP SAYS; SPONSOR/CRO/SITE COOPERATION MUST GET BETTER, ACIL CONFERENCE HEARS
Executive Summary
Outsourcing in drug development will increase about 30% from year to year, "a tremendous increase" over the next five to 10 years, Corning-Besselaar VP-Business Development Jeffrey McMullen told the ACIL Second Annual Life Sciences Forum Jan. 31 in Arlington, Va.